Concepedia

A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE®

Alfred von Krempelhuber, Jens Vollmar, Rolf Pokorny, Petra Rapp, Niels Wulff, Barbara Petzold, Amanda Handley, Lyn Mateo, Henriette Siersbol, Herwig Kollaritsch,

Vaccine · 2009 · 123 citations · 31 references

DOIFull text

Open access

Concepts

References

31

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

Jorma Paavonen, David Jenkins, F. Xavier Bosch et al. · The Lancet · 2007 · 1.3K citations

, , +17

Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective

John W. A. Findlay, W. Smith, J.W. Lee et al. · Journal of Pharmaceutical and Biomedical Analysis · 2000 · 582 citations

, , +11

Complications of Smallpox Vaccination, 1968

J. Michael Lane, Frederick L. Ruben, J Neff et al. · New England Journal of Medicine · 1969 · 547 citations

, , +17

Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox

Patricia L. Earl, Jeffrey L. Americo, Linda S. Wyatt et al. · Nature · 2004 · 461 citations

, , +9

Smallpox vaccine–induced antibodies are necessary and sufficient for protection against monkeypox virus

Yvette Edghill‐Smith, Hana Golding, Jody Manischewitz et al. · Nature Medicine · 2005 · 455 citations

, , +13